veratridine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotroneo, P; Ghirlanda, G; Greco, AV; Greene, DA; Magnani, P; Manto, A; Menzinger, G; Sima, AA; Tilli, P; Uccioli, L | 1 |
| Barrett, CJ; Schultz, HD; Sun, SY; Ustinova, EE | 1 |
2 other study(ies) available for veratridine and Alloxan Diabetes
| Article | Year |
|---|---|
Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes.
Topics: Acetylcholine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Heart; In Vitro Techniques; Insulin; Male; Neurons; Parasympathetic Nervous System; Rats; Rats, Sprague-Dawley; Somatostatin; Tetrodotoxin; Veratridine | 1993 |
Oxidative stress impairs cardiac chemoreflexes in diabetic rats.
Topics: Administration, Oral; Afferent Pathways; Animals; Antioxidants; Bradykinin; Capsaicin; Chemoreceptor Cells; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Heart; Instillation, Drug; Lipid Peroxides; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reflex; Sympathectomy; Vagotomy; Vagus Nerve; Veratridine; Vitamin E | 2000 |